{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:51:35Z","timestamp":1786981895198,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"DOI":"10.1007\/s11547-022-01574-6","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T16:33:10Z","timestamp":1671467590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Muscle mass loss in breast cancer patients of reproductive age (\u2264\u200945\u00a0years) undergoing neoadjuvant chemotherapy"],"prefix":"10.1007","author":[{"given":"Federica","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Lambertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"De Giorgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Razeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1736-0697","authenticated-orcid":false,"given":"Alberto Stefano","family":"Tagliafico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"key":"1574_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics. CA Cancer J Clin 72:7\u201333","journal-title":"CA Cancer J Clin"},{"key":"1574_CR2","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.annonc.2020.09.006","volume":"31","author":"M Lambertini","year":"2020","unstructured":"Lambertini M, Peccatori FA, Demeestere I, Amant F, Wyns C et al (2020) ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO clinical practice guidelines. Ann Oncol 31:1664\u20131678","journal-title":"Ann Oncol"},{"key":"1574_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s13058-014-0427-5","volume":"16","author":"HA Azim Jr","year":"2014","unstructured":"Azim HA Jr, Partridge AH (2014) Biology of breast cancer in young women. Breast Cancer Res 16:427","journal-title":"Breast Cancer Res"},{"key":"1574_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12885-020-6645-6","volume":"20","author":"XM Zhang","year":"2020","unstructured":"Zhang XM, Dou QL, Zeng Y, Yang Y, Cheng ASK, Zhang WW (2020) Sarcopenia as a predictor of mortality in women with breast cancer: a meta-analysis and systematic review. BMC Cancer 20:172","journal-title":"BMC Cancer"},{"key":"1574_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00330-018-5663-0","volume":"29","author":"F Rossi","year":"2019","unstructured":"Rossi F, Valdora F, Barabino E, Calabrese M, Tagliafico AS (2019) Muscle mass estimation on breast magnetic resonance imaging in breast cancer patients: comparison between psoas muscle area on computer tomography and pectoralis muscle area on MRI. Eur Radiol 29:494\u2013500","journal-title":"Eur Radiol"},{"key":"1574_CR6","doi-asserted-by":"publisher","first-page":"25714","DOI":"10.18632\/oncotarget.25394","volume":"9","author":"F Mazzuca","year":"2018","unstructured":"Mazzuca F, Onesti CE, Roberto M et al (2018) Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines. Oncotarget 9:25714\u201325722","journal-title":"Oncotarget"},{"key":"1574_CR7","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/JCO.20.03399","volume":"39","author":"LA Korde","year":"2021","unstructured":"Korde LA, Somerfield MR, Carey LA, Crews JR, Denduluri N et al (2021) Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline. J Clin Oncol 39:1485\u20131505","journal-title":"J Clin Oncol"},{"key":"1574_CR8","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.ejca.2010.02.015","volume":"46","author":"F Sardanelli","year":"2010","unstructured":"Sardanelli F, Boetes C, Borisch B et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 46:1296\u20131316","journal-title":"Eur J Cancer"},{"key":"1574_CR9","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1007\/s00330-015-3807-z","volume":"25","author":"RM Mann","year":"2015","unstructured":"Mann RM, Balleyguier C, Baltzer PA et al (2015) Breast MRI: EUSOBI recommendations for women\u2019s information. Eur Radiol 25:3669\u20133678","journal-title":"Eur Radiol"},{"key":"1574_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1148\/rg.2021200134","volume":"41","author":"B Reig","year":"2021","unstructured":"Reig B, Lewin AA, Du L, Heacock L, Toth HK et al (2021) Breast MRI for evaluation of response to neoadjuvant therapy. Radiographics 41:665\u2013679","journal-title":"Radiographics"},{"key":"1574_CR11","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1007\/s00330-020-06799-5","volume":"30","author":"F Rossi","year":"2020","unstructured":"Rossi F, Torri L, Lambertini M, De Giorgis S, Calabrese M, Tagliafico AS (2020) Muscle mass loss after neoadjuvant chemotherapy in breast cancer: estimation on breast magnetic resonance imaging using pectoralis muscle area. Eur Radiol 30:4234\u20134241","journal-title":"Eur Radiol"},{"key":"1574_CR12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s11547-022-01450-3","volume":"127","author":"AS Tagliafico","year":"2022","unstructured":"Tagliafico AS, Bignotti B, Torri L, Rossi F (2022) Sarcopenia: how to measure, when and why. Radiol Med 127:228\u2013237","journal-title":"Radiol Med"},{"key":"1574_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13550-021-00834-2","volume":"11","author":"J Han","year":"2021","unstructured":"Han J, Harrison L, Patzelt L, Wu M, Junker D et al (2021) Imaging modalities for diagnosis and monitoring of cancer cachexia. EJNMMI Res 11:94","journal-title":"EJNMMI Res"},{"key":"1574_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.690320","volume":"11","author":"E Blondeaux","year":"2021","unstructured":"Blondeaux E, Massarotti C, Fontana V, Poggio F, Arecco L et al (2021) The PREgnancy and FERtility (PREFER) study investigating the need for ovarian function and\/or fertility preservation strategies in premenopausal women with early breast cancer. Front Oncol 11:690320","journal-title":"Front Oncol"},{"key":"1574_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"1574_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247","journal-title":"Eur J Cancer"},{"key":"1574_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/uog.122","volume":"22","author":"JM Bland","year":"2003","unstructured":"Bland JM, Altman DG (2003) Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol 22:85\u201393","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1574_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159\u2013174","journal-title":"Biometrics"},{"key":"1574_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12885-022-09443-1","volume":"22","author":"M Amitani","year":"2022","unstructured":"Amitani M, Oba T, Kiyosawa N, Morikawa H, Chino T et al (2022) Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer. BMC Cancer 22:327","journal-title":"BMC Cancer"},{"key":"1574_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10120-014-0381-z","volume":"18","author":"Y Kodera","year":"2015","unstructured":"Kodera Y (2015) More than 6 months of postoperative adjuvant chemotherapy results in loss of skeletal muscle: a challenge to the current standard of care. Gastric Cancer 18:203\u2013204","journal-title":"Gastric Cancer"},{"key":"1574_CR21","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3389\/fphys.2020.01037","volume":"11","author":"BN VanderVeen","year":"2020","unstructured":"VanderVeen BN, Murphy EA, Carson JA (2020) The impact of immune cells on the skeletal muscle microenvironment during Cancer Cachexia. Front Physiol 11:1037","journal-title":"Front Physiol"},{"key":"1574_CR22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.acra.2016.10.014","volume":"24","author":"RM Strigel","year":"2017","unstructured":"Strigel RM, Rollenhagen J, Burnside ES et al (2017) Screening breast MRI outcomes in routine clinical practice: comparison to BI-RADS benchmarks. Acad Radiol 24:411\u2013417","journal-title":"Acad Radiol"},{"key":"1574_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.arr.2009.02.001","volume":"8","author":"A Saini","year":"2009","unstructured":"Saini A, Faulkner S, Al-Shanti N, Stewart C (2009) Powerful signals for weak muscles. Ageing Res Rev 8:251\u2013267","journal-title":"Ageing Res Rev"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-022-01574-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-022-01574-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-022-01574-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T16:49:50Z","timestamp":1671468590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-022-01574-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":23,"alternative-id":["1574"],"URL":"https:\/\/doi.org\/10.1007\/s11547-022-01574-6","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,19]]},"assertion":[{"value":"10 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Rossi F, Brunetti N, De Giorgis G, Razeti MG, Calabrese M and Tagliafico AS declare they have no financial interests. Lambertini M reports advisory role for Roche, Lilly, Novartis, Astrazeneca, Pfizer, Seagen, Gilead, MSD and Exact Sciences, speaker honoraria from Roche, Lilly, Novartis, Pfizer, Sandoz, Libbs, and Takeda, and Travel Grants from Gilead outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by our institutional review board (CER009\/2018).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Figs.\n                      \n                      ,\n                      \n                      (2a and 2b) and\n                      \n                      (3a and 3b).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}